Caron Introduces New Environmental Test Chambers and Refrigerated Incubators - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Caron Introduces New Environmental Test Chambers and Refrigerated Incubators

Caron's new environmentally controlled stability chambers include large-capacity environmental chambers (7000 Series) and refrigerated incubators (7001 Series) in two-door (50 cu. ft.) and three-door (75 cu. ft.) configurations.

The new stability chambers are designed in accordance with FDA ICH Q1A Guidelines and can be used for numerous customer applications, including shelf-life studies, stability and package testing, and temperature-elevation studies. The stability chambers have several new features, including humidity control, self-closing doors with locks, CFC-free foam insulation, and a full-color user interface. These new design features help yield up to 71% in energy savings. The environmental chambers and refrigerated incubators also have a 7” color touchscreen that has easy-to-read icons and a display that can be operated with gloves on. Both products are constructed of stainless steel, making them easy to clean and highly resistant to corrosion.



blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here